Entry
Name
MicroRNAs in cancer - Rattus norvegicus (rat)
Description
MicroRNA (miRNA) is a cluster of small non-encoding RNA molecules of 21 - 23 nucleotides in length, which controls gene expression post-transcriptionally either via the degradation of target mRNAs or the inhibition of protein translation. Using high-throughput profiling, dysregulation of miRNAs has been widely observed in different stages of cancer. The upregulation (overexpression) of specific miRNAs could lead to the repression of tumor suppressor gene expression, and conversely the downregulation of specific miRNAs could result in an increase of oncogene expression; both these situations induce subsequent malignant effects on cell proliferation, differentiation, and apoptosis that lead to tumor growth and progress. The miRNA signatures of cancer observed in various studies differ significantly. These inconsistencies occur due to the differences in the study populations and methodologies used. This pathway map shows the summarized results from various studies in 9 cancers, each of which is presented in a review article.
Class
Human Diseases; Cancer: overview
BRITE hierarchy
Pathway map
Organism
Rattus norvegicus (rat) [GN:
rno ]
Gene
114851 Cdkn1a; cyclin-dependent kinase inhibitor 1 [KO:K06625 ]
117282 Hnrnpk; heterogeneous nuclear ribonucleoprotein K [KO:K12886 ]
140942 Ddit4; DNA damage-inducible transcript 4 protein [KO:K08270 ]
170911 Pik3ca; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922 ] [EC:2.7.1.153 ]
24205 Apc; adenomatous polyposis coli protein [KO:K02085 ]
24628 Pdgfb; platelet-derived growth factor subunit B precursor [KO:K17386 ]
24851 Tpm1; tropomyosin alpha-1 chain isoform Tpm1.6cy [KO:K10373 ]
25125 Stat3; signal transducer and activator of transcription 3 [KO:K04692 ]
25163 Cdkn2a; cyclin-dependent kinase inhibitor 2A [KO:K06621 ]
25266 Pdgfa; platelet-derived growth factor subunit A precursor [KO:K04359 ]
25267 Pdgfra; platelet-derived growth factor receptor alpha precursor [KO:K04363 ] [EC:2.7.10.1 ]
25279 Cyp24a1; 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial precursor [KO:K07436 ] [EC:1.14.15.16 ]
252971 Socs1; suppressor of cytokine signaling 1 [KO:K04694 ]
25358 Timp3; metalloproteinase inhibitor 3 precursor [KO:K16866 ]
25496 Notch1; neurogenic locus notch homolog protein 1 precursor [KO:K02599 ]
25513 Pik3r1; phosphatidylinositol 3-kinase regulatory subunit alpha [KO:K02649 ]
25603 Marcks; myristoylated alanine-rich C-kinase substrate [KO:K12561 ]
25648 Slc7a1; high affinity cationic amino acid transporter 1 [KO:K13863 ]
25705 Zeb1; zinc finger E-box-binding homeobox 1 [KO:K09299 ]
25738 Plcg1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [KO:K01116 ] [EC:3.1.4.11 ]
287871 Rptor; regulatory-associated protein of mTOR [KO:K07204 ]
29337 Plcg2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 [KO:K05859 ] [EC:3.1.4.11 ]
29492 Notch2; neurogenic locus notch homolog protein 2 precursor [KO:K20994 ]
297173 RSA-14-44; ras homolog gene family, member A [KO:K04513 ]
29741 Pik3r2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649 ]
299284 Dicer1; endoribonuclease Dicer [KO:K11592 ] [EC:3.1.26.-]
299611 Apc2; adenomatous polyposis coli protein 2 [KO:K02085 ]
303477 Igf2bp1; insulin-like growth factor 2 mRNA-binding protein 1 [KO:K17391 ]
304785 Slc45a3; solute carrier family 45 member 3 [KO:K15379 ]
311071 Zeb2; zinc finger E-box-binding homeobox 2 [KO:K23560 ]
313488 Reck; reversion-inducing cysteine-rich protein with Kazal motifs precursor [KO:K17461 ]
363140 Rassf1; ras association domain-containing protein 1 isoform 2 [KO:K09850 ]
366508 Pik3cd; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922 ] [EC:2.7.1.153 ]
367858 Hrasl1; HRas proto-oncogene, GTPase like 1 [KO:K02833 ]
406162 Notch4; neurogenic locus notch homolog protein 4 precursor [KO:K20996 ]
445442 Thbs1; thrombospondin-1 isoform 1 precursor [KO:K16857 ]
56761 Notch3; neurogenic locus notch homolog protein 3 precursor [KO:K20995 ]
58960 Map2k2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369 ] [EC:2.7.12.2 ]
60430 Mcl1; induced myeloid leukemia cell differentiation protein Mcl-1 homolog [KO:K02539 ]
60664 Pik3r3; phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649 ]
64031 Pdcd4; programmed cell death protein 4 [KO:K16865 ]
65205 Mmp16; matrix metalloproteinase-16 precursor [KO:K07996 ] [EC:3.4.24.-]
684111 E2f2; transcription factor E2F2 isoform X2 [KO:K09389 ]
81504 Grb2; growth factor receptor-bound protein 2 [KO:K04364 ]
81736 Nfkb1; nuclear factor NF-kappa-B p105 subunit isoform 2 [KO:K02580 ]
81809 Tgfb2; transforming growth factor beta-2 proprotein precursor [KO:K13376 ]
83571 Cdkn1b; cyclin-dependent kinase inhibitor 1B [KO:K06624 ]
83785 Vegfa; vascular endothelial growth factor A isoform 6 precursor [KO:K05448 ]
84017 Hmga2; high mobility group protein HMGI-C [KO:K09283 ]
85243 Pik3cb; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922 ] [EC:2.7.1.153 ]
85385 Shc1; SHC-transforming protein 1 isoform b [KO:K06279 ]
Reference
Authors
Lee YS, Dutta A
Title
MicroRNAs in cancer.
Journal
Reference
Authors
Babashah S, Soleimani M
Title
The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis.
Journal
Reference
Authors
Garzon R, Calin GA, Croce CM
Title
MicroRNAs in Cancer.
Journal
Reference
Authors
Chen PS, Su JL, Hung MC
Title
Dysregulation of microRNAs in cancer.
Journal
Reference
Authors
Ling H, Zhang W, Calin GA
Title
Principles of microRNA involvement in human cancers.
Journal
Reference
Authors
Iorio MV, Croce CM
Title
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review.
Journal
Reference
Authors
Sayed D, Abdellatif M
Title
MicroRNAs in development and disease.
Journal
Reference
Authors
Wang Q, Wang S, Wang H, Li P, Ma Z
Title
MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment.
Journal
Reference
Authors
Song JH, Meltzer SJ
Title
MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers.
Journal
Reference
Authors
Chu Y, Zhu H, Lv L, Zhou Y, Huo J
Title
MiRNA s in oesophageal squamous cancer.
Journal
Neth J Med 71:69-75 (2013)
Reference
Authors
Kan T, Meltzer SJ
Title
MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma.
Journal
Reference
Authors
Smith CM, Watson DI, Michael MZ, Hussey DJ
Title
MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma.
Journal
Reference
Authors
Song S, Ajani JA
Title
The role of microRNAs in cancers of the upper gastrointestinal tract.
Journal
Reference
Authors
Liu WH, Yeh SH, Chen PJ
Title
Role of microRNAs in hepatitis B virus replication and pathogenesis.
Journal
Reference
Authors
Hrasovec S, Glavac D
Title
MicroRNAs as Novel Biomarkers in Colorectal Cancer.
Journal
Reference
Authors
Liu H
Title
MicroRNAs in breast cancer initiation and progression.
Journal
Reference
Authors
Li SD, Zhang JR, Wang YQ, Wan XP
Title
The role of microRNAs in ovarian cancer initiation and progression.
Journal
Reference
Authors
Zabolotneva AA, Zhavoronkov A, Garazha AV, Roumiantsev SA, Buzdin AA
Title
Characteristic patterns of microRNA expression in human bladder cancer.
Journal
Reference
Authors
Saini S, Majid S, Dahiya R
Title
Diet, microRNAs and prostate cancer.
Journal
Related pathway
KO pathway